R FX7 (also known as RFX domain containing 2 (RFXDC2)) belongs to the RFX family, which comprises seven transcription factors 1, 2 . These members share a highly conserved wingedhelix DNA-binding domain (DBD) recognizing X-box motifs 3, 4 . RFX1-4 and RFX6 bear additional domains involved in transactivation or homo-and heterodimer formation, whereas RFX5 and RFX7 exhibit no identifiable domains beyond the DBD 2 . According to phylogenetic analyses, RFX family members are subdivided into three clades: RFX1-3; RFX4 and RFX6; and RFX5 and RFX7.
R FX7 (also known as RFX domain containing 2 (RFXDC2)) belongs to the RFX family, which comprises seven transcription factors 1, 2 . These members share a highly conserved wingedhelix DNA-binding domain (DBD) recognizing X-box motifs 3, 4 . RFX1-4 and RFX6 bear additional domains involved in transactivation or homo-and heterodimer formation, whereas RFX5 and RFX7 exhibit no identifiable domains beyond the DBD 2 . According to phylogenetic analyses, RFX family members are subdivided into three clades: RFX1-3; RFX4 and RFX6; and RFX5 and RFX7.
RFX family members play important roles in several biological processes. For instance, RFX2-4 regulate genes essential for the formation of cilia, which are required for normal development of several organs and cell types. RFX2 is necessary for spermatogenesis, as shown by the sterility of knockout mice 5, 6 . Rfx4 deletion leads to incomplete neural tube closure 7, 8 , whereas Rfx3 -/-animals show defects in left-right asymmetry and brain development 9, 10 .
Moreover, Rfx3
-/-mice also exhibit abnormalities of the pancreatic endocrine compartments 11 . Similarly, Rfx6 deficiency leads to severe defects in pancreatic islet development, and inactivating mutations cause a monogenic form of diabetes in human neonates 12 . Finally, Rfx5 regulates transcription of major histocompatibility complex (MHC) genes, which are fundamental for proper T cell homeostasis and function. Transcription of MHC genes is coordinated by a multiprotein complex including RFX5 (refs 13, 14 ), and inactivating mutations of RFX5 cause a severe immunodeficiency condition known as bare lymphocyte syndrome.
To date, the only study on the function of Rfx7 has reported a role in neural tube closure during Xenopus laevis development 15 . Rfx7 regulates ciliogenesis through controlling Rfx4 expression. Genome-wide association studies in humans have linked RFX7 to body-fat distribution and tumor development [16] [17] [18] [19] [20] [21] . In particular, alterations in RFX7 have been associated with human lymphoid cancers [16] [17] [18] [19] 21 and the development of lymphoma in mouse models 22, 23 . Those findings suggest that RFX7 is a potentially interesting gene in the context of metabolic disorders and hematologic malignancies. However, its function remains completely uncharacterized in mammalian cells.
Here, we investigated the role of Rfx7. We observed prominent Rfx7 expression in immune-system organs and cells. We therefore generated mice with specific Rfx7 deletion in the hematopoietic compartment. These mice exhibited a decrease in the number of NK cells along with defective NK cell-mediated immunity. Through transcriptomic and molecular analyses, we defined Rfx7-target genes, which are largely linked to cellular metabolism. In agreement with these findings, Rfx7-deficient NK cells presented features of spontaneous activation. Heterozygosity for Rptor, encoding a cofactor of the metabolic checkpoint kinase mTORC1 complex, partially rescued those defects. Furthermore, the cytokine IL-15 rescued Rfx7-deficient NK lymphocytes by engaging the Jak pathway, which was thus essential for survival of these pseudoactivated NK cells. Rfx7 therefore is an important gatekeeper of NK cell resting state and homeostasis, a prerequisite for optimal responses. 
The transcription factor Rfx7 limits metabolism of NK cells and promotes their maintenance and immunity
Wilson
Results
Rfx7 is prominently expressed in lymphoid organs. Rfx7 is conserved among higher vertebrates, and it has 93% amino acid identity and an indistinguishable DBD between humans and mice ( Supplementary Fig. 1a-c) . Thus, analysis of mouse Rfx7 is highly relevant to the understanding of its human counterpart. We generated Rfx7 conditional-deficient mice, enabling deletion of the DBD and generating a frame shift ( Supplementary Fig. 1d ). The deleted exons are common to all annotated isoforms 24 . To study the role of Rfx7 in the immune system, we crossed these mice to the Vav1-iCre deleter strain, (expressing an improved variant of Cre recombinase (iCre) under the control of the Vav1 promoter; hereafter called Vav Rfx7 fl/fl ), leading to deletion in hematopoietic cells and their progenitors. In addition, germline deletion of Rfx7 was obtained. Rfx7 −/− mice were born from heterozygous parents at a frequency of 7% (n = 161), instead of the expected 25%, a result revealing a central developmental role of Rfx7. First, we detailed the expression of Rfx7 in different mouse tissues. The Rfx7 transcript was abundant in lymphoid organs and lymphoid cell subsets (Fig. 1a,b ), in agreement with publicly available datasets 25 . We next tested Rfx7 protein expression in selected organs, by using cell lysates derived from Rfx7 −/− mice to ensure immunoblot specificity (Fig. 1c) . Rfx7 was clearly detected in the spleen and lymph nodes and-to a lesser extent-in the brain. Although its predicted molecular weight was 157 kDa, immunoblot analysis revealed that Rfx7 had a major isoform close to 250 kDa (Fig. 1c) . Overexpressed mouse and human RFX7 migrated similarly (Fig. 1d) , thus suggesting that this factor is heavily modified at the post-translational level. The abundance of Rfx7 mRNA, measured by qRT-PCR in the indicated tissues (relative to 18 S) (a) and flow cytometry-sorted immune subsets (relative to 18 S and Polr2a) (b) derived from C57BL/6 mice. c, Rfx7 expression in the spleen, lymph node (LN), kidney, and brain tissues isolated from wild-type (WT) and Rfx7-deficient (KO) mice, determined by immunoblot (IB) analysis. Actin was used as loading control. MW, molecular weight. d, Migration of human and mouse Rfx7 overexpressed in HEK293T cells, determined by immunoblot analysis on the basis of the indicated tag. e, Rfx7's presence in nuclear (N) and cytoplasmic (C) fractions of C57BL/6 splenocytes. Lamin B1 and caspase 3 were used as nuclear and cytoplasmic markers, respectively. f, Predicted bipartite nuclear localization sequences in mouse and human proteins (bold). g, HEK293T cells were co-transfected with expression vectors encoding wild-type or the indicated mutant mouse Rfx7 and mCherry. Rfx7 nuclear localization (colocalization with DAPI) was quantified on mCherry-positive cells with Image Stream analysis; a representative example is shown. Results represent the mean ± s.d. of three technical replicates (a,b) and are representative of at least two independent experiments (a-e,g).
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We next investigated the subcellular localization of this transcription factor. Rfx7 was detected in the nuclear fraction obtained from total splenocytes (Fig. 1e) . According to bioinformatic predictions, three stretches of basic residues, also conserved in human RFX7, were identified as part of potential bipartite nuclear localization signals (NLSs) (Fig. 1f) . Mutagenesis showed that nuclear localization was lost when Rfx7 was mutated at amino acid positions 658 and/or 674 (Fig. 1g) , whereas mutation at position 695 had no effect. These results show that Rfx7 is highly expressed in immune cells and corroborate its role as a bona fide transcription factor.
Rfx7 plays a cell-intrinsic role in NK cell homeostasis. First, we ensured that Rfx7 deletion was effective in multiple hematopoietic subsets from Vav Rfx7 fl/fl compared with Vav Rfx7 wt/wt control mice. Deletion was virtually complete in T, B, and NK cells ( Supplementary  Fig. 2a,b) . Given the high expression of Rfx7 in hematopoietic cells, we next used flow cytometry to assess the abundance of the main lymphoid populations and of conventional dendritic cells. Whereas most subsets were unaltered, we observed markedly lower NK cell percentages and numbers in Vav Rfx7 fl/fl mice than in Rfx7 fl/fl and Vav Rfx7 wt/wt control mice (Fig. 2a,b ). To further examine whether this defect was intrinsic to NK cells, we generated congenically marked Vav Rfx7 fl/fl origin efficiently repopulated the spleen in reconstituted mice, NK cells were severely underrepresented (Fig. 2c) . These data indicate that Rfx7 is required for NK cell homeostasis in a cellintrinsic manner.
Rfx7-deficient NK cells present a maintenance problem. Because the Rfx7 transcript was abundantly expressed throughout NK cell maturation ( Supplementary Fig. 3a) , we more closely examined individual stages of NK cell development. NK cell precursors in the BM are characterized by CD122 expression; acquisition of NK1.1 followed by DX5 denotes progression to the stages of immature and mature NK cells, respectively. We observed that the percentages and numbers of total CD122 + cells as well as the proportions of CD122 + precursor, immature, and mature NK cells were not altered in the BM of Vav Rfx7 fl/fl mice, as compared with Rfx7 fl/fl and Vav Rfx7 wt/wt control mice (Fig. 3a,b) . These results suggested that the loss of Rfx7 affected the peripheral population of mature NK cells. Along these lines, when splenic NK cell maturation was measured by the expression of CD11b and CD27, NK cells exhibiting the most mature phenotype (CD11b + CD27 -) were more severely decreased in Rfx7-deficient NK cells compared with control NK cells (Fig. 3c) .
To test whether Rfx7 was important after NK cell commitment had occurred, we generated Ncr1-iCre Rfx7 fl/fl mice (expressing iCre under the control of the promoter of Ncr1, which encodes an NK cell receptor expressed at the immature-mature stage, hereafter referred to as Ncr Rfx7 fl/fl ), thus leading to Rfx7 deletion at the immaturemature transition. These mice, compared with Vav Rfx7 wt/wt mice, exhibited fewer NK cells in the spleen (Fig. 3d ) and in other peripheral tissues, such as the blood and liver ( Supplementary Fig. 3b (Fig. 4a) . We therefore set up in vitro co-cultures of congenically marked Rfx7-deficient and control NK cells supplied with different amounts of IL-15. In the presence of a low amount of IL-15 (1 ng/ml), Rfx7-deficient NK cells were preferentially lost after 3 d of culture (Fig. 4b) . This result was due to decreased survival, as indicated by the absence of proliferation and the slightly increased percentage of dying cells (as shown by CTV and DAPI nuclear staining, respectively; Fig. 4c) . Notably, increasing amounts of IL-15 (3 ng/ml or 10 ng/ml) reverted the defect of Rfx7 -/-NK cells, which were able to survive as well as or even better than their wild-type counterparts (Fig. 4b, c) . A similar dose-response curve was observed for the cytokine IL-2 (Fig. 4d) ; moreover, after 4 d of culture at intermediate and high doses (30 ng/ ml and 100 ng/ml, respectively) of IL-2, a greater proportion of Rfx7-deficient NK cells underwent cell division (Fig. 4e) .
We next examined the cytokine-mediated survival response of Rfx7-deficient NK cells in vivo. Exogenous IL-2 was complexed with anti-IL-2 (S4B6), which potentiates the biologic activity of this cytokine 26 , and the complex was administered to Ncr Rfx7 fl/fl mice for 4 d. This treatment completely restored the defect in the Rfx7-deficient NK cell population, showing that even when starting from lower proportions, these lymphocytes expanded to percentages and numbers similar to those of control NK cells (Fig. 4f) ) mice (a) and n = 9 mice per group (c), and are representative of at least three independent experiments (a-c). Statistical comparison between the experimental condition lacking Rfx7 and controls were performed (a,c); *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001; two-tailed Student's t test.
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Rfx7 regulates expression of metabolism-related genes. To uncover the molecular mechanisms underlying the effects of Rfx7 deficiency, we performed global RNA-sequencing analyses on Vav Rfx7
wt/wt and Vav Rfx7 fl/fl NK cells isolated from the BM and spleen, then performed a paired differential expression analysis. Likelihood-ratio tests identified 1,636 genes significantly altered in
Vav Rfx7
fl/fl compared with Vav Rfx7 wt/wt NK cells (855 upregulated and 781 downregulated; P ≤ 0.05). In support of the finding that Rfx7 is important in NK cell maintenance, transcription factors and cytokine receptors involved in differentiation were not substantially affected in the absence of Rfx7 (Supplementary Table 1a,b) . Functional classification of biological processes and gene ontology analysis showed that genes related to cellular and metabolic processes constituted the majority of differentially expressed genes and were significantly overrepresented (Fig. 5a,b) .
To validate the RNA-sequencing results, we focused on the 50 top-ranked genes (false discovery rate (FDR) ≤ 0.00015), specifically on genes robustly and consistently altered by Rfx7 deficiency across BM-and spleen-derived NK cells. Two clusters clearly separating Rfx7-deficient from Rfx7-sufficient NK cells in both organs were delineated by unsupervised hierarchical clustering (Fig. 5c ). The first cluster corresponded to 14 downregulated genes (Fig. 5c, d ), whereas the second cluster corresponded to six upregulated genes (Fig. 5c,e) . We performed qRT-PCR on selected genes for validation (11 genes from cluster 1, and 1 gene from cluster 2; Supplementary Fig. 4a ). We performed this analysis on NK cells derived from Vav Rfx7 wt/wt :Vav Rfx7 fl/fl mixed BM chimeras to exclude nonintrinsic alterations. We confirmed the expected differences in transcript abundance for all genes, except for Ifi27l2a (an interferon-responsive gene) and Dynlt1b (the most significantly upregulated gene) ( Supplementary Fig. 4a ). We also assessed protein expression of the top targets Rec8, Dyrk1b, and Ddit4. Owing to the low number of NK cells, we focused on ex vivo total T cells, which also presented lower mRNA abundance for these genes in the absence of Rfx7 (Supplementary Fig. 4b ). The expression of these proteins was decreased, although the DNA damage-responsive protein Ddit4 was only mildly affected ( Supplementary Fig. 4c ). Notably, a clear decrease in these proteins was observed in the splenic T cell-depleted fraction from Vav Rfx7 fl/fl mice, demonstrating the broad relevance of Rfx7 in the expression of these targets.
Rfx7-deficient NK lymphocytes also revealed slightly decreased mRNA expression of Rfx5 mRNA, the only Rfx factor found among differentially expressed genes, and of MHC class I genes (Fig. 5c Statistical comparisons between the experimental condition lacking Rfx7 and controls were performed (a-d); *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001; twotailed Student's t test.
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and Supplementary Fig. 4d ,e). However, these cells exhibited normal MHC class I surface expression ( Supplementary Fig. 4f ), in agreement with previous findings that mechanisms regulating its display compensate for moderate differences in transcript abundance 27 . Altogether, the data presented in this section indicate that Rfx7 deficiency alters a subset of genes linked to cell metabolism.
Top differentially expressed genes are targets of Rfx7. To assess the likelihood of differentially expressed genes being directly transactivated by Rfx7, we took advantage of in silico binding-site predictions. Promoters of genes in cluster 1 (downregulated in the Rfx7-deficient NK cells) and cluster 2 (upregulated), and of a group of nonmodulated genes (hereafter called cluster 0) were analyzed for the presence of putative binding sites for Rfx7 and for Rfx5, whose DBD has the closest homology to that of Rfx7. Interestingly, a significant enrichment in both motifs was observed in the promoters of downregulated genes, whereas a nonsignificant trend was found for upregulated genes (Fig. 6a) . Moreover, analysis for binding sites of two unrelated transcription factors did not show significant enrichment ( Supplementary Fig. 5a ).
We therefore cloned the promoters of nine genes from cluster 1 into a luciferase reporter vector, which was cotransfected with plasmids encoding either Rfx7 or its NLS-mutated version, which was used as a control. All promoters except Ucp2 were transactivated, and the highest induction was observed for Rec8 and Mxd4 (Fig. 6b) . We also determined whether enforced Rfx7 expression in HEK293T cells induced transcription of endogenous target genes. For that purpose, Rfx7-encoding plasmid or controls (empty or containing an NLS-mutated version) were cotransfected with a GFP-expressing vector. Notably, GFP + cells showed increased mRNA abundance of MXD4, PIK3R3, and DYRK1B (Fig. 6c) , thus indicating that even in human kidney-derived cells, Rfx7 regulates these genes.
To define the sequence recognized by Rfx7, we focused on the Rec8 promoter and generated truncated versions. We identified that ) mice (f), and mean ± s.d. of n = 3 technical replicates per condition (b-e). Results are representative of at least three independent experiments (a-f). Statistical comparisons between the experimental condition lacking Rfx7 and control were performed (a,c,e,f); *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, not significant (NS). Unpaired two-tailed Student's t test (a,f) and paired two-tailed Student's t test (c,e).
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NaTuRe ImmuNOlOGy the region between -182 and -30 bp upstream of the transcriptional start site was essential for transactivation (Fig. 6d) . Four putative binding sites in this region were selected for site-directed mutagenesis and demonstrated the presence of regulatory elements at positions -150 to -142 and -81 to -73 (Fig. 6d) . Interestingly, concomitant mutation of these two sequences did not further diminish promoter transactivation, thus suggesting that their regulatory activity is interdependent. In agreement with this finding, a promoter version truncated at position -121 was weakly transactivated by Rfx7 (Fig. 6e) . Mutation of the remaining element at position -81 to -73 abrogated transactivation in this system, corroborating the functional effect of this putative binding site.
Finally, we set-up chromatin immunoprecipitation assays using anti-Rfx7 to determine whether the promoters of selected target genes were occupied by Rfx7. Because of the paucity of NK cells, we performed these experiments in ex vivo total T cells and confirmed that promoter regions of Rec8, Mxd4, and Ddit4 were enriched by Rfx7 immunoprecipitation (Fig. 6f) . Together, these results support that the differential gene expression identified through RNA sequencing is driven by Rfx7. 
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Loss of Rfx7 leads to a heightened metabolic state. The proteins encoded by the Rfx7-target genes, such as Mxd4 and Ddit4, act as inhibitors of metabolic pathways, thus suggesting that Rfx7-deficient NK cells would exhibit increased activity. We therefore assessed cell size and granularity, which are correlated with metabolism, and found both were significantly increased in Rfx7-deficient NK cells (Fig. 7a and Supplementary Fig. 6a,b) . This phenotype was independent of the maturation stage (Fig. 7b) and was already present in the BM (Supplementary Fig. 6c,d) . Moreover, Rfx7 deficiency broadly affected size and granularity in immune subsets ( Supplementary Fig. 6e ), whereas its overexpression in HEK293T cells led to a decrease in cell size (Supplementary Fig. 6f) . Notably, deletion of Rfx5 did not exert similar effects ( Supplementary  Fig. 6g ) 14 , thus uncovering a unique function of Rfx7. Next, we measured the expression of the proliferation marker Ki67 and of the amino acid transporter CD98, as well as the activity of mTORC1 by assessing S6 phosphorylation. We observed that these parameters were augmented in splenic NK cells lacking Rfx7, including at individual maturation stages (Fig. 7c-e) . We also assessed the metabolic rate of these NK cells through Seahorse analysis. Oxygen consumption and the extracellular acidification rate were both increased at the basal state (Fig. 7f) . Together, our results indicate that Rfx7-deficient NK cells present a heightened energetic state.
To evaluate the role of mTORC1 in this phenotype, we bred Vav Rfx7 fl/fl mice onto Rptor fl/wt , which was expected to slightly impair mTORC1 signaling [28] [29] [30] [31] . Notably, Rptor heterozygosity moderately restored splenic Rfx7-deficient NK cell percentages and numbers, with respect to those of Rptor fl/wt controls (Fig. 7g) , although mice on the Rptor fl/wt background exhibited smaller spleens (Fig. 7g) . Rptor heterozygosity also partially normalized Rfx7-deficient NK cell size and granularity (Fig. 7g) , indicating that one of the functions of Rfx7 is limiting mTORC1 signaling 28 . 
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Nonetheless, Rfx7-deficient NK cells were rescued in vitro by supraphysiological doses of IL-15 (10 ng/ml), which further engaged mTORC1. Importantly, IL-15 also activates the Jak1/3-STAT5 signaling axis, whose basal activity was unaltered in the absence of Rfx7 (Fig. 7h) . Notably, high IL-15 stimulation (10 ng/ml) engaged both mTORC1 and Jak-STAT5 pathways in control and Rfx7-deficient Rptor fl/wt mice (g) were performed; *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001; two-tailed Student's t test.
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NK cells, and tofacitinib, a Jak1/3 inhibitor, selectively decreased survival of the latter cells over 3 d of culture (Fig. 7h,i ). This effect was partly due to myeloid cell leukemia sequence 1, a known STAT5 target 32 ( Supplementary Fig. 6h ). Therefore, our results suggest that the increased activation state of Rfx7-deficient NK cells is not detrimental in itself, but it hinders survival in the context of insufficient Jak-STAT5 engagement.
Rfx7 is essential for optimal NK cell-mediated immunity.
Finally, we sought to understand the functional effect of Rfx7 deficiency on NK cell-mediated immunity. First, we examined whether Rfx7-deficient NK cells presented an altered receptor repertoire. Although the expression of several receptors was slightly modulated, the overall expression pattern was maintained ( Supplementary Fig. 7a ). Next, we assessed whether the killing ability on a per-cell basis was altered by Rfx7 deficiency. To this end, NK cells were isolated from Ncr Rfx7 fl/fl and Ncr Rfx7 wt/wt mice and cultured together with RMA-S and RMA-H60 target cells, which lack MHC class I expression and express the activating H60 ligand 33 , respectively, or with control RMA cells. The killing abilities of Rfx7-deficient and control NK cells were comparable (Fig. 8a) .
We therefore investigated whether the altered numbers of Rfx7-deficient NK cells found in vivo affected NK cell-mediated immunity. To this end, β 2 microglobulin (B2m)-deficient splenocytes, which also lack expression of MHC class I molecules, were transferred , day 3.5) (d-g) mice, and are representative of (a-c) or are a pool of (d-g) two independent experiments. Statistical comparisons between the experimental condition lacking Rfx7 and control were performed; *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001; two-tailed Student's t test.
Articles
NaTuRe ImmuNOlOGy into Vav Rfx7
fl/fl and Vav Rfx7 wt/wt mice, and their elimination was quantified. Notably, the ability of Vav Rfx7 fl/fl mice to reject β 2 mdeficient targets was significantly lower than that of Vav Rfx7 wt/wt mice (Fig. 8b) . To corroborate the hypothesis that this result was largely linked to reduced NK cell numbers, we administered IL-2-anti-IL-2 complexes to Rfx7-deficient mice to rescue NK cells ( Supplementary Fig. 7b ) and then assessed β 2 m-deficient cell rejection. Under these conditions, the recognition of MHC class Ideficient cells in Ncr Rfx7 fl/fl mice was substantially closer to that observed in Vav Rfx7 wt/wt mice (Fig. 8c) . We thus postulated that Rfx7 might strongly affect antiviral responses at early time points. To investigate this hypothesis, we infected Ncr Rfx7 fl/fl and Ncr Rfx7 wt/wt mice with murine cytomegalovirus (MCMV). The numbers of total and Ly49H + Rfx7-deficient NK cells were lower 1.5 d after infection, whereas the defect was milder at day 3.5 ( Fig. 8d,e) . In addition, granzyme B production was lower early after infection (Fig. 8f) . This finding was consistent with RNA-sequencing results (Supplementary Table 2 ) that were further supported by the observation that in uninfected mice, granzyme A production was slightly decreased, whereas the level of the cytokine IFN-γ in Rfx7-deficient NK cells was comparable to that in control NK cells (Supplementary Fig. 7c ).
We finally assessed the resistance of Ncr Rfx7 fl/fl mice to MCMV infection. Importantly, the spleen and lung in Ncr Rfx7 fl/fl mice exhibited significantly higher viral titers early after infection, whereas the defect was corrected a few days after the onset of the inflammatory reaction (Fig. 8g ). These data demonstrate the importance of Rfx7 in normal NK cell homeostasis and antiviral immunity in the initial phase of the response.
Discussion
Rfx7 is an understudied protein, which has been ascribed a transcriptional function on the basis of phylogenetic analyses. We found that this factor localizes to the nucleus through a bipartite NLS and directly regulates selected genes. Moreover, we identified regulatory sequences required for Rfx7-mediated transactivation. These data further suggest that Rfx7 activity requires multiple binding sites, possibly implying DNA-loop formation. In agreement with available datasets, our results also indicate that Rfx7 is subject to multiple posttranslational modifications 34 . Complex regulation of its activity is not surprising, given the functions of this protein in immunity and beyond. Indeed, mice with full-body deletion of Rfx7 are born at sub-Mendelian ratios, thus revealing a developmental role, possibly related to ciliogenesis, that deserves further investigation.
The generation of a conditional-knockout mouse model allowed us to study Rfx7 in immune cells, in which it is prominently expressed. Our results highlighted a significant defect in NK lymphocyte percentages and numbers. These cells exhibited an intrinsic survival problem mainly affecting the most mature peripheral subsets. Whereas Rfx7-ablated NK lymphocytes displayed only moderately altered receptor repertoire and production of cytotoxic mediators, their decreased numbers affected NK cellmediated immunity in vivo. This effect was observed in the context of both 'missing-self ' and antiviral responses, thus uncovering an essential role of Rfx7 in containing MCMV replication in the early phases of infection.
Interestingly, gene ontology enrichment analysis revealed that differentially expressed genes were related to metabolic processes. A closer examination of the phenotype of Rfx7-deficient NK cells highlighted their heightened metabolic features. The finding that immune populations such as T cells, which were not decreased in number, presented morphological and transcriptional alterations similar to those in peripheral NK cells and the validation of differentially expressed genes as direct Rfx7 targets corroborated that this factor directly limits cell activation and metabolism.
We found that an increased metabolic rate in Rfx7-deficient NK cells negatively affected their survival; although this result is counterintuitive, it highlights the importance of maintaining quiescence. Although this concept is often neglected in immunity, similar examples have been shown. For instance, deletion of Tsc1¸ encoding an inhibitor of mTORC1, in T and NK cells leads to improper cellular activation and apoptosis 28, 35 . In agreement with these findings, our results showed that Rptor heterozygosity mitigated the defects caused by Rfx7 deficiency.
Indications of how Rfx7 limits the activation state of NK cells arose from RNA-sequencing analyses. The Rfx7 target Ddit4 inhibits mTORC1 through positive regulation of the TSC complex 36 . In addition, Mxd4 and Pik3ip1 encode proteins antagonizing Myc and phosphatidylinositol-3-OH kinase, respectively [37] [38] [39] [40] , whereas the target gene Dyrk1b, which is associated with a form of metabolic syndrome, encodes a protein that interferes with sonic hedgehog signaling and promotes gluconeogenesis 41, 42 . Rfx7 therefore controls genes, whose products counter proliferative, activating, and anabolic pathways via mTORC1-dependent and mTORC1-independent cascades.
The lower survival of Rfx7-deficient NK cells was corrected by supraphysiological concentrations of IL-15. Because features of metabolic deregulation, but not the survival defect, were detected in developing Rfx7-deficient NK cells in the BM, the bioavailability of IL-15 in this primary lymphoid organ may potentially be higher than that in the periphery, a hypothesis compatible with experimental data 43 . Although IL-15 drives coordinated engagement of STAT5 and mTORC1, Rfx7 deficiency favors the latter pathway. IL-15 activation rescued Rfx7-deleted splenic NK cells, indicating that these lymphocytes were not inherently defective and even presented an advantage if provided with the appropriate Jak-mediated signaling, an effect partly dependent on the STAT5 target Mcl-1 (refs 32, [44] [45] [46] ). This finding underlines the importance of harmonized activation of these cascades in NK cells.
While regulation of metabolism by Rfx factors has been previously reported-for instance, Rfx3 and Rfx6 regulate glucokinase in pancreatic cells 11, 47 -the understanding of the transcriptional mechanisms maintaining cellular quiescence remains fragmentary. Foxo and Foxp1 transcription factors have been involved in such mechanisms 39, 40, [48] [49] [50] . The reported functions and target genes suggest distinct actions of Foxo transcription factors compared with Rfx7. Interestingly, Foxp1 maintains quiescence in T cells in part through regulation of Pik3ip1 expression. Because this gene is also controlled by Rfx7, future experiments are needed to understand their coordinate regulation of gene expression.
RFX7 has been associated with altered body-fat distribution; a role as a suppressor of metabolic pathways is consistent with this observation 20 , thus suggesting that Rfx7 may be relevant beyond the immune system. Interestingly, transformed cells are characterized by increased metabolic rates, and alterations in RFX7 have been associated with cancer, particularly lymphoid cancers [16] [17] [18] [19] [21] [22] [23] . Whereas spontaneous activation caused by Rfx7 deficiency leads to cell death in NK cells, we found that this cell death is not the case for other lymphocytes, suggesting a role of Rfx7 in limiting their activation and as a tumor suppressor. Altogether, our data position this transcription factor as a regulator of immunometabolism, and its manipulation might be attractive in treating a range of immune, malignant, and metabolic diseases.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41590-018-0144-9.
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Methods
Mice. Rfx7-floxed mice were generated (IngeniousTargeting) on a C57BL/6 background through targeted gene disruption, as described in Supplementary  Fig. 1d . For genotyping, the Rfx7-floxed alleles were detected by PCR amplification with a set of primers amplifying a 315-bp WT band and a 438-bp floxed band (forward primer, 5′ -GTCACTCCCCAAACAGGAAGTCTATGATG-3′ ; reverse primer, 5′ -CCTCTAGTCCCTCCCATGTTTCTTGTC-3′ ). Rfx7 fl/fl mice were crossed to Vav-iCre and Cd4-Cre (The Jackson Laboratory) mice, or an Ncr1-iCre deleter strain 51 .
Rfx7
-/-mice were generated by crossing Rfx7 fl/fl to the CMV-Cre deleter strain (Jackson Laboratory), thus also leading to deletion of the LoxPflanked region in germ cells and allowing for selection of Rfx7-deleted offspring and elimination of the CMV-Cre transgene in the following generation. Rptor fl/fl mice were as previously described 52 . Conditionally deleted Rfx7 fl/fl and control mice, CD45.1 + congenic, B2m -/-(Jackson Laboratory), and C57BL/6 mice, all on a C57BL/6 (H-2 b ) background, were bred at the animal facility of the University of Lausanne. Rfx5 -/-and littermate controls on a mixed Sv129/C57Bl/6 (H-2 b ) background were bred at the animal facility of the University of Geneva Medical School 53 . Sex-and age-matched 6-to 12-week-old mice were used. All animal experimental protocols were approved by the Veterinary Office regulations of the State of Vaud, Switzerland, and all methods were performed in accordance with the Swiss guidelines and regulations.
Mixed bone marrow chimeras. Mixed BM chimeras were generated as previously described 54 , except that a total of 5 × 10 6 BM cells were injected intravenously into recipient mice.
NK cell purification and in vitro culture or in vivo transfer. Rfx7-deficient and congenically (CD45.1) marked control NK cells were purified (STEMCELL Technologies 19855). NK cells were then cocultured in vitro with recombinant mouse IL-15 or IL-2 (Peprotech) for 3 or 4 d, as indicated. IL-15 was used at 10 ng/ml (high), 3 ng/ml (medium), or 1 ng/ml (low) doses, and IL-2 was used at 100 ng/ml (high), 30 ng/ml (medium), or 10 ng/ml (low) doses. The medium used for in vitro experiments was as previously described 55 .
For in vivo transfer, congenically marked NK cells from Vav Rfx7
fl/fl or Vav Rfx7 wt/wt mice were CTV labeled, and approximately 1.8 × 10 6 NK cells were adoptively cotransferred into C57BL/6 hosts.
Intracellular staining and PMA/ionomycin stimulation. Intracellular staining for Ki67 (SolA15), p-STAT5 Y694 (SRBCZX) (all from eBioscience) and p-S6 ribosomal protein (S235/236; D57.2.2E; from Cell Signaling) were performed with the intracellular staining kit from Invitrogen (00-5523-00) or with a standard paraformaldehyde/methanol protocol. Briefly, after surface staining, cells were fixed with fixation/permeabilization buffer (Invitrogen (00-5123)) or with 2% paraformaldehyde, then permeabilized with permeabilization buffer (Invitrogen (00-8333)) or with 90 °C methanol. Intracellular phosphostaining was performed for 1 h at 22-28 °C in the dark. A secondary antibody coupled to an APC fluorochrome (Donkey F(ab′ ) 2 , anti-rabbit IgG, multispecies, Southern Biotech, cat. no. 6444-31) was used in addition to non-directly conjugated phosphorylated antibodies. For resting conditions, cells were left in medium at 37 °C for 40 min to 1 h, and for IL-15-stimulated conditions, cells were stimulated with 10 ng/ml of IL-15 for 40 min at 37 °C before staining.
For intracellular cytokine detection, freshly isolated splenocytes were cultured in medium at 37 °C and stimulated with 0.1 μ M PMA and 1 mg/ml ionomycin for 1 h, then with brefeldin A at a final concentration of 10 μ g/ml for 3.5 h. After surface staining, cells were fixed with intracellular fixation buffer (eBioscience 00-8222-49) for 15 min, then permeabilized with permeabilization buffer (eBioscience 00-8333-56) for 15 min. Intracellular staining for IFN-γ (F3 IGH 48) and granzyme A (3G8.5) was performed with antibodies diluted into permeabilization buffer. Granzyme B (GB12, Life Technologies) staining was performed after fixation (25 min at 22-28 °C) and permeabilization with the FoxP3 transcription factor-staining buffer set (eBioscience 00-5523-00). Intracellular staining was then performed for 30 min at 22-28 °C (with the antibody diluted in permeabilization buffer).
Murine cytomegalovirus infection. MCMV (expressing m157) was derived from the bacterial artificial chromosome pSM3fr 3.3 (ref. 56 ). MCMV was propagated on M2-10B4 cells, and viral stocks were purified as previously described 57, 58 . Mice were infected intravenously with 2 × 10 5 PFU MCMV. Organs from infected mice were snap-frozen in liquid nitrogen and stored at -80 °C until further use. For determination of the viral load, serial dilutions of organ homogenates were propagated on monolayers of M2-10B4 cells as previously described 58 .
Rfx7 constructs and transfection. For expression of mouse Rfx7, the pEF-Dest51-mRfx7-V5/6× His (C-terminal) vector was purchased from Source BioScience LifeSciences. Nucleotides encoding the putative NLS sequences (predicted by http://nls-mapper.iab.keio.ac.jp/cgi-bin/NLS_Mapper_form.cgi/) were mutated through site-directed mutagenesis. For expression of the human protein, the Lenti-ORF clone of RFX7 with a Myc-DDK tag (C-terminal) sequence was purchased from OriGene. HEK293T cells were transfected with PEI reagent at a 1:1.5 (DNA/PEI) ratio. For studying the subcellular localization of Rfx7, at least 1 × 10 6 HEK293T cells for each condition were analyzed. Cells were transfected with an mCherry-encoding construct plus wild-type or mutant Rfx7-encoding vectors. 24 h post-transfection, cells were fixed with 4% paraformaldehyde and permeabilized with 0.5% saponin in PBS and 1% FCS; the cells were then stained with mouse anti-V5 (mouse IgG1; Thermo Fisher Scientific MA5-15253) followed by FITC rat anti-mouse IgG1 (Southern Biotech 1144-02). In addition, nuclear dye (DAPI, Thermo Fischer Scientific) was added. Rfx7-and mCherry-positive cells were selected, and as a measure of nuclear localization, the similarity of DAPI and Rfx7 staining in the 'dilate(object(DAPI, tight)1)' mask was calculated. Values between 1 and 2.5 were considered to indicate partial nuclear localization.
Preparation and in vivo administration
For NK cell size analysis, at least 3 
Replication
Describe whether the experimental findings were reliably reproduced.
For experiments that required technical troubleshootings, data were not considered until all quality controls were met. Experiments were repeated as reported in the figure legends and were reliably reproduced.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
Randomisation was not relevant for our purpose. As we aimed at identifying the function of Rfx7, all experimental groups were constituted according to the genotypes of the animals or cells (deficient /sufficient/ ectopic expression).
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
N/A. Blinding was not relevant for our purpose.
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
Software
Policy information about availability of computer code
Describe the software used to analyze the data in this study.
N/A
For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for providing algorithms and software for publication provides further information on this topic.
Materials and reagents
Policy information about availability of materials
Materials availability
Indicate whether there are restrictions on availability of unique materials or if these materials are only available for distribution by a for-profit company.
All unique material used are readily available from the authors 
Data presentation
For all flow cytometry data, confirm that:
1. The axis labels state the marker and fluorochrome used (e.g. CD4-FITC).
2. The axis scales are clearly visible. Include numbers along axes only for bottom left plot of group (a 'group' is an analysis of identical markers).
3. All plots are contour plots with outliers or pseudocolor plots. Methodological details 5 . Describe the sample preparation. Mice were euthanized, and femurs, spleen, blood, and liver were collected from mice. Cell suspensions from spleen were prepared by mashing the organ on a filter tissue in PBS and treated with red blood cell lysis buffer during 5 minutes at room temperature (RT), washed, resupended in PBS 2% FCS, and counted. For BM lymphocytes, the BM was flushed out from the femur and tibia with PBS, 3mM EDTA, 2% FCS and were passed through a 26 gauge needle. The cell suspension was then treated with red blood cell lysis buffer for 5 minutes, washed, resuspended in PBS 2% FCS, and counted. Liver samples were obtained from mice that were perfused with heparin in PBS; then, the organs were mashed in HBSS, 2% FCS, 10mM HEPES and filtered through 70 um cell strainer. The cells were then resuspended in 35% Percoll and then centrifuged at 2200 rpm for 30 min at room temperature. The pellets were treated with red blood cell lysis buffer for 5 minutes, washed, resuspended in PBS 2% FCS, and counted. For blood NK cells, blood was collected in heparin-containing tubes and centrifuged. The cells were treated with red blood cell lysis buffer for 5 minutes at RT, washed, resuspended in PBS 2% FCS. FC data were collected on a BD Biosciences flow cytometer using BD FACSDiva™ software. The analysis of flow cytometry data was performed using FlowJo software version 9.4.11.
8. Describe the abundance of the relevant cell populations within post-sort fractions.
BM NK cells were FACS-sorted as NK1.1+CD122+CD3-CD19-cells, and SP NK cells were sorted as NK1.1+Ncr1+CD3-CD19-cells. B and T cells from total spleen were first stained against CD3, NK1.1, CD19. B cells were sorted as CD19+CD3-NK1.1-, and T cells as CD3+CD19-NK1.1-. Purity of the sorted cells was determined by running a fraction of the sorted sample and was equal or superior to 99 %.
9. Describe the gating strategy used. Flow cytometry data analysis was performed by excluding debris and doublets; then a relatively large gate was placed around the lymphocyte population according to forward scatter and side scatter. To investigate and to quantify NK cell populations either NK1.1 or CD122 versus lineage (CD3 and CD19) was used as illustrated in Fig. 2 and 3 . The gating strategy to determine frequencies of B, T, NKT, and DC populations is explained in Fig. 2 .
Tick this box to confirm that a figure exemplifying the gating strategy is provided in the Supplementary Information.
